Zhang YJ - Search Results

1

Persistent peripheral blood EBV-DNA positive with high expression of PD-L1 and upregulation of CD4 + CD25 + T cell ratio in early stage NK/T cell lymphoma patients may predict worse outcome.

Li PF, Mao YZ, Bai B, Gao Y, Zhang YJ, Li ZM, Jiang WQ, Huang HQ. Li PF, et al. Among authors: zhang yj. Ann Hematol. 2018 Dec;97(12):2381-2389. doi: 10.1007/s00277-018-3467-6. Epub 2018 Aug 16. Ann Hematol. 2018. PMID: 30116872

2

[Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases].

He YF, Zhang YJ, Li YH, Lin TY, Xia YF, Lu TX, Huang HQ, Jiang WQ, Xian CG, He YJ, Guan ZZ. He YF, et al. Among authors: zhang yj. Ai Zheng. 2006 Dec;25(12):1538-42. Ai Zheng. 2006. PMID: 17166382 Chinese.

3

[Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].

Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX. Zou GR, et al. Among authors: zhang yj. Ai Zheng. 2006 Dec;25(12):1543-9. Ai Zheng. 2006. PMID: 17166383 Chinese.

4

Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of stage IE/IIE extranodal natural killer/T cell lymphoma, nasal type: 13-year follow-up in 135 patients.

Wang L, Xia ZJ, Huang HQ, Lu Y, Zhang YJ. Wang L, et al. Among authors: zhang yj. Int J Hematol. 2012 Nov;96(5):617-23. doi: 10.1007/s12185-012-1174-y. Epub 2012 Sep 16. Int J Hematol. 2012. PMID: 22983648 Clinical Trial.

5

Combination of gemcitabine, L-asparaginase, and oxaliplatin (GELOX) is superior to EPOCH or CHOP in the treatment of patients with stage IE/IIE extranodal natural killer/T cell lymphoma: a retrospective study in a cohort of 227 patients with long-term follow-up.

Wang L, Wang WD, Xia ZJ, Zhang YJ, Xiang J, Lu Y. Wang L, et al. Among authors: zhang yj. Med Oncol. 2014 Mar;31(3):860. doi: 10.1007/s12032-014-0860-4. Epub 2014 Jan 31. Med Oncol. 2014. PMID: 24481637

6

Hepatitis B virus infection correlates with poor prognosis of extranodal natural killer/T cell lymphoma.

Wang L, Wu-Xiao ZJ, Chen XQ, Zhang YJ, Lu Y, Xia ZJ. Wang L, et al. Among authors: zhang yj. Leuk Lymphoma. 2015 Apr;56(4):936-41. doi: 10.3109/10428194.2014.953146. Epub 2014 Oct 7. Leuk Lymphoma. 2015. PMID: 25110821

7

Prophylactic cervical lymph node irradiation provides no benefit for patients of stage IE extranodal natural killer/T cell lymphoma, nasal type.

Wang L, Xia ZJ, Lu Y, Zhang YJ. Wang L, et al. Among authors: zhang yj. Med Oncol. 2015 Jan;32(1):320. doi: 10.1007/s12032-014-0320-1. Epub 2014 Nov 28. Med Oncol. 2015. PMID: 25429828

8

A modified international prognostic index including pretreatment hemoglobin level for early stage extranodal natural killer/T cell lymphoma.

Wang L, Xia ZJ, Lu Y, Wang QX, Niu SQ, Huang HQ, Zhang YJ. Wang L, et al. Among authors: zhang yj. Leuk Lymphoma. 2015;56(11):3038-44. doi: 10.3109/10428194.2015.1026817. Epub 2015 Mar 28. Leuk Lymphoma. 2015. PMID: 25747971

9

Radical surgery may be not an optimal treatment approach for pulmonary MALT lymphoma.

Wang L, Xia ZJ, Zhang YJ, Huang HQ, Lin TY, Lu Y. Wang L, et al. Among authors: zhang yj. Tumour Biol. 2015 Aug;36(8):6409-16. doi: 10.1007/s13277-015-3329-y. Epub 2015 Mar 24. Tumour Biol. 2015. PMID: 25801243

10

CD38 expression predicts poor prognosis and might be a potential therapy target in extranodal NK/T cell lymphoma, nasal type.

Wang L, Wang H, Li PF, Lu Y, Xia ZJ, Huang HQ, Zhang YJ. Wang L, et al. Among authors: zhang yj. Ann Hematol. 2015 Aug;94(8):1381-8. doi: 10.1007/s00277-015-2359-2. Epub 2015 Apr 14. Ann Hematol. 2015. PMID: 25865943

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,712 results

Search Page

Filters